D. E. Shaw & Co., Inc. Enochian Biosciences Inc Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.93 - $8.73 $37,739 - $170,706	19,554 Added 43.56%	64,443 $124,000
Q1 2022 May 16, 2022	SELL	$4.42 - $9.0 $268,519 - $546,759	-60,751 Reduced 57.51%	44,889 $370,000
Q4 2021 Feb 14, 2022	BUY	$6.71 - $12.55 $708,844 - $1.33 Million	105,640 New	105,640 $770,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.